Welcome to LookChem.com Sign In|Join Free

CAS

  • or

842170-41-6

5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid, also known as 5-(3,4-Methylenedioxyphenyl)nicotinic acid, is a chemical compound with the molecular formula C12H7NO5. It is a derivative of nicotinic acid, featuring a benzo[1,3]dioxole ring attached to the 5-position of the nicotinic acid structure. 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid is of interest in the field of organic chemistry and may have potential applications in the synthesis of pharmaceuticals or other chemical products due to its unique structure. The benzo[1,3]dioxole ring provides additional functionality and reactivity to the molecule, which can be exploited in various chemical reactions and transformations.

842170-41-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 842170-41-6 Structure

  • Basic information

    1. Product Name: 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid
    2. Synonyms: 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid
    3. CAS NO:842170-41-6
    4. Molecular Formula: C13H9NO4
    5. Molecular Weight: 243.21486
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 842170-41-6.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid(842170-41-6)
    11. EPA Substance Registry System: 5-(Benzo[1,3]dioxol-5-yl)-nicotinic acid(842170-41-6)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 842170-41-6(Hazardous Substances Data)

842170-41-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 842170-41-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,2,1,7 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 842170-41:
(8*8)+(7*4)+(6*2)+(5*1)+(4*7)+(3*0)+(2*4)+(1*1)=146
146 % 10 = 6
So 842170-41-6 is a valid CAS Registry Number.

842170-41-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(1,3-benzodioxol-5-yl)pyridine-3-carboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:842170-41-6 SDS

842170-41-6Downstream Products

842170-41-6Relevant articles and documents

Suzuki coupling reaction for the solid-phase preparation of 5-substituted nicotinic acid derivatives

Fernàndez, Joan-Carles,Solé-Feu, Laia,Fernández-Forner, Dolors,De La Figuera, Natalia,Forns, Pilar,Albericio, Fernando

, p. 581 - 585 (2007/10/03)

The application of the Suzuki coupling reaction to the preparation of small combinatorial libraries using 5-bromonicotinic acid as a scaffold onto three different types of solid support (Wang, Rink, and BAL resin) is described. The application of the Suzuki coupling reaction to the preparation of small combinatorial libraries using 5-bromonicotinic acid as a scaffold onto three different types of solid support (Wang, Rink, and BAL resin) is described.

NICOTINAMIDE-BASED KINASE INHIBITORS

-

Page 20-21, (2008/06/13)

A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 842170-41-6